Dizal and Burning Rock's NGS─based companion diagnostic for lung cancer receives China NMPA marketing nod
Dizal, a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, and Burning Rock, a leading company in the field of precision oncology, jointly announced that the companion diagnostic (CDx) …